A 53-year-old man of Puerto-Rican origin presented to the endocrinology clinic after undergoing bilateral adrenalectomy for multifocal pheochromocytomas. He had a prior history of morbid obesity, obstructive sleep apnea, diabetes, and hypertension. He was followed by his primary care physician for persistent hematuria ranging from 3 to 35 red blood cells per high power field on urinalysis, as well as urinary frequency, weak stream, and nocturia three times per night for the previous three years. He had been unable to tolerate an empiric trial of tamsulosin for benign prostate hypertrophy due to orthostatic dizziness. Negative symptoms pertinent to this case include flushing, headaches, sweating, palpitations, anxiety, blurry vision, or dizziness. His family history was notable for death from a myocardial infarction in his father at the age of 57 and an unknown genitourinary cancer in his sister. There was no family history of adrenal tumors, hyperparathyroidism, medullary thyroid cancer, renal cancer, or pituitary tumors. The patient was a smoker with several past attempts at quitting.Due to the persistent hematuria, smoking, and the family history of cancer, a CT urogram was performed to screen for bladder cancer. While no abnormalities were seen within the urogenital tract, bilateral, irregular, heterogeneous large adrenal masses (Figure 1) measuring 4.7 cm (R) and 1.6 cm (L) were noted. In addition, a prominent and suspicious lymph node was identified. Biochemical characterization of the adrenal masses revealed significantly elevated 24-hour urine normetanephrine (1090 micrograms/gram of creatinine; normal range, 0–400 micrograms/gram of creatinine), leading to the diagnosis of pheochromocytoma. Urine metanephrine level was within normal range. Cushing's syndrome was ruled out with an undetectable late-night salivary cortisol level. Electrolyte levels, kidney function, and complete blood count were within normal limits. In search for additional, extra-adrenal foci, a metaiodobenzylguanidine (MIBG) scan was performed but was nondiagnostic due to lack of cardiac activity. Nevertheless, given the available imaging and biochemical findings, there was concern for malignant pheochromocytoma, and the patient ultimately underwent an open bilateral adrenalectomy and paracaval lymph node excision. Intraoperatively, the patient required vasopressor support and a large amount of crystalloid resuscitation (13 liters) to maintain hemodynamic stability. Intraoperative ultrasound was used to identify one mesenteric lymph node of mildly suspicious appearance which was resected, in addition to a large retroperitoneal paracaval lymph node.Open in a separate windowFigure 1CT scan of the abdomen showing the right adrenal tumor ((a), arrow) and the left adrenal tumor ((b), arrow) prior to adrenalectomy.Surgical pathology confirmed pheochromocytomas in the bilateral adrenal glands (right, 5.0 x 3.5 x 2.5 cm, and left, 1.5 x 1.3 x 1.0 cm) which were both confined to the adrenal glands. The paracaval lymph node was described as paraganglioma versus metastatic pheochromocytoma measuring 1.6 cm in the greatest dimension with no lymphoid tissue identified. The immediate postoperative course was unremarkable. The patient was started on life-long glucocorticoid and mineralocorticoid replacement. His diabetes and hypertension resolved.
PatientID: None
KindredID: 1
Case: M, 53Y0M, Puerto-Rican
DiseaseAssertion: VHL
FamilyInfo: His family history was notable for death from a myocardial infarction in his father at the age of 57 and an unknown genitourinary cancer in his sister. There was no family history of adrenal tumors, hyperparathyroidism, medullary thyroid cancer, renal cancer, or pituitary tumors.
CasePresentingHPOs: HP:0002666; HP:0006748; HP:0002668; HP:0001513; HP:0002870; HP:0000819; HP:0000822; HP:0100293; HP:0000790; HP:0000079 (Pheochromocytoma, Adrenal pheochromocytoma, Paraganglioma, Obesity, Obstructive sleep apnea, Diabetes, Hypertension, Muscle fiber hypertrophy, Hematuria, Abnormality of the urinary system)
CaseHPOFreeText: Prior history of morbid obesity, obstructive sleep apnea, diabetes, hypertension, benign prostate hypertrophy, persistent hematuria, urinary frequency, weak stream, and nocturia. He presented with multifocal pheochromocytomas. CT urogram showed bilateral, irregular, heterogeneous large adrenal masses diagnosed as pheochromocytomas and a prominent and suspicious lymph node. He underwent an open bilateral adrenalectomy and paracaval lymph node resection resulting in a paraganglioma diagnosis. Surgical pathology confirmed pheochromocytomas in the bilateral adrenal glands. Patient was identified as having type 2C VHL.
CaseNotHPOs: HP:0000119; HP:0012211 (Abnormality of the genitourinary system, Abnormal renal physiology)
CaseNotHPOFreeText: CT urogram showed no abnormalities within the urogenital tract. Cushing's syndrome was ruled out with an undetectable late-night salivary cortisol level. Electrolyte levels, kidney function, and complete blood count were within normal limits.
CasePreviousTesting: Coding exons and adjacent intron nucleotides of the 12 targeted genes associated with hereditary pheochromocytoma syndromes were amplified and then sequenced using PCR and next-generation sequencing.
PreviouslyPublished: N/A
SupplementalData: N/A
Variant: p.Y175C (c.524A>G)
LegacyVariant: N/A
CaseProblemVariantFreeText: N/A
ClinVarID: 36905, https://www.ncbi.nlm.nih.gov/clinvar/variation/36905/
CAID: N/A
gnomAD: N/A
VariantEvidence: in vitro studies showed that under both normoxic and hypoxic conditions, Y175C VHL functions similarly to the WT with regard to HIFα degradation.
MutationType: missense_variant;transition
CivicName: Y175C (c.524A>G)